Search clinical trials for: technetium Tc 99m epratuzumab

Total 171 results

Gilead Sciences

Unknown

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Lymphoma

Switzerland, United States, Italy, Sweden, Austria
Gilead Sciences

Unknown

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Lymphoma

Switzerland, United States, Italy, Sweden, Austria
Oregon Health and Science University
Ionis Pharmaceuticals, Inc.

Recruiting

carDIo-ttranSSfOrm nucLEar Imaging Study (DISSOLvE)

Amyloidosis | Transthyretin Amyloid Cardiomyopathy

United States
Navidea Biopharmaceuticals

Completed

Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes

Melanoma | Breast Cancer

United States
Navidea Biopharmaceuticals

Completed

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Melanoma | Breast Cancer

United States, Israel
Mathew S. Maurer
National Heart, Lung, and Blood Institute (NHLBI); Yale University; Boston Medical... and other collaborators

Recruiting

Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations (SCAN-MP)

Amyloid Cardiomyopathy, Transthyretin-Related

United States
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors

Pituitary Tumors

United States
Boston Scientific Corporation

Completed

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Hepatocellular Carcinoma

United States
University of North Carolina, Chapel Hill
National Institute of General Medical Sciences (NIGMS)

Completed

Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin

Non-alcoholic Steatohepatitis

United States
University of Washington
National Cancer Institute (NCI)

Completed

SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy

Lung Carcinoma | Malignant Neoplasm

United States
University of California, San Diego
Cardinal Health 414, LLC

Terminated

Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium

Endometrial Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

Eyelid Sebaceous Gland Carcinoma

United States
Endocyte

Completed

Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

Head and Neck Cancer | Bladder Cancer | Pancreas Cancer | Testicular Cancer | Recurrent or Metastatic Cancer
Endocyte

Completed

Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer

Ovarian Cancer | Endometrial Cancer

United States
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Endocyte

Completed

Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients

Ovarian Cancer | Healthy Volunteers

United States
Edwin Wu
Astellas Pharma Global Development, Inc.

Terminated

Half-Dose Radiopharmaceutical in Wide Beam Reconstruction (REGA-1102)

Myocardial Infarction | Ischemic Heart Disease

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer

Breast Cancer

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI); Mitaka USA, Inc.

Completed

Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer

Stage I Breast Cancer | Stage II Breast Cancer

United States
Buddhist Tzu Chi General Hospital

Completed

18F-fluorocholine PET/CT for Hyperparathyroidism

Hyperparathyroidism

Taiwan
University Hospital Inselspital, Berne

Active, not recruiting

ATTR Amyloidosis in Elderly Patients With Aortic Stenosis

Aortic Stenosis Symptomatic | Amyloidosis Cardiac

Switzerland
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Ictal SPECT With Intra-arterial Injection

Epilepsy

Belgium
Assiut University

Not yet recruiting

Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies

Bone Metastases | Urogenital Cancer
Endocyte

Completed

Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma

Recurrent Endometrial Carcinoma | Ovarian Carcinoma
Mayo Clinic

Recruiting

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

Breast Neoplasm

United States
Otsuka Pharmaceutical Co., Ltd.
Covance

Completed

Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects

Dyspeptic Subjects

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

Head and Neck Cancer
University of Pittsburgh

Completed

Absorptive Clearance in the Cystic Fibrosis Airway

Cystic Fibrosis

United States
Centre Paul Strauss

Completed

Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer

Breast Cancer

France
UNICANCER

Terminated

Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer

Breast Cancer

France
Mayo Clinic
National Cancer Institute (NCI)

Completed

Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer

Breast Cancer | Lymphedema

United States
Proactina S.A.
Pharmathen S.A.; ConsulTech GmbH; pharmtrace

Completed

Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma

Glioma (Diagnosis)

Hungary, France
Lantheus Medical Imaging

Completed

CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI

Myocardial Infarction

United States, Canada, Brazil
Lantheus Medical Imaging

Completed

A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.

Diabetes

United States, Canada
Lantheus Medical Imaging

Completed

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

Diabetes Mellitus, Type 2 | Coronary Restenosis

Puerto Rico, United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat

Head and Neck Cancer

United States
Navidea Biopharmaceuticals

Completed

An Evaluation of the Safety of Intravenous Tc 99m Tilmanocept and a Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH

Nonalcoholic Steatohepatitis | NASH - Nonalcoholic Steatohepatitis

United States
National Taiwan University Hospital

Recruiting

A Proof-of-concept Study Evaluating the Microbiota-gut-brain Axis

Parkinson Disease

Taiwan
University of Washington
National Cancer Institute (NCI)

Completed

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging

Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7

United States
Lantheus Medical Imaging

Completed

A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects

Kawasaki Disease

United States, Taiwan, Canada
Tel-Aviv Sourasky Medical Center

Unknown

The Added Value of Quantification of Lung Function in Patients Undergoing Radiotherapy, Using Tc-99m-MAA SPECT-CT

Lung Cancer
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer

Breast Cancer

United States
Lantheus Medical Imaging

Completed

A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

Coronary Artery Disease

United States, Canada, Puerto Rico, Finland
Kettering Health Network

Completed

Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer (Lymphoseek)

Breast Cancer

United States
Lantheus Medical Imaging

Completed

A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

Kawasaki Disease

United States, Brazil, Canada, Taiwan, Philippines, Thailand, Korea, Republic of
Navidea Biopharmaceuticals
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.

Liver Metastases | Colorectal Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

Stage IV Liver Cancer | Stage IVA Liver Cancer | Stage IVB Liver Cancer | Metastatic Liver Carcinoma

United States
M.D. Anderson Cancer Center

Recruiting

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

Breast Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma

United States

Search clinical trials for: technetium Tc 99m epratuzumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations